{"id":29729,"date":"2024-08-19T13:23:42","date_gmt":"2024-08-19T12:23:42","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=29729"},"modified":"2024-08-19T13:46:34","modified_gmt":"2024-08-19T12:46:34","slug":"resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/","title":{"rendered":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant"},"content":{"rendered":"\n<p>Voir l&#8217;article en entier ici : <a href=\"https:\/\/www.inserm.fr\/dossier\/resistance-antibiotiques\/\">R\u00e9sistance aux antibiotiques \u00b7 Inserm, La science pour la sant\u00e9<\/a><\/p>\n\n\n\n<p>Les antibiotiques ont permis de faire consid\u00e9rablement reculer la mortalit\u00e9 associ\u00e9e aux maladies infectieuses au cours du 20<sup>e<\/sup>&nbsp;si\u00e8cle. H\u00e9las, leur utilisation massive et r\u00e9p\u00e9t\u00e9e a conduit \u00e0 l\u2019apparition de bact\u00e9ries r\u00e9sistantes \u00e0 ces m\u00e9dicaments. Qui plus est, les animaux d\u2019\u00e9levage ing\u00e8rent au moins autant d\u2019antibiotiques que les humains&nbsp;! R\u00e9sultat&nbsp;: la r\u00e9sistance bact\u00e9rienne est devenue un ph\u00e9nom\u00e8ne global et pr\u00e9occupant. Pour \u00e9viter le pire, la communaut\u00e9 internationale se mobilise. Mais la route est longue&#8230;<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Comprendre la r\u00e9sistance aux antibiotiques<\/h2>\n\n\n\n<p>\u00c0 l\u2019origine, les antibiotiques sont des mol\u00e9cules naturellement synth\u00e9tis\u00e9es par des microorganismes pour lutter contre des bact\u00e9ries concurrentes pr\u00e9sentes dans leur environnement. Depuis leur d\u00e9couverte, leur utilisation en m\u00e9decine humaine et v\u00e9t\u00e9rinaire a conduit au d\u00e9veloppement de&nbsp;<strong>plusieurs familles d\u2019antibiotiques, naturels, semi-synth\u00e9tiques ou de synth\u00e8se, qui s\u2019attaquent sp\u00e9cifiquement \u00e0 une bact\u00e9rie ou \u00e0 un groupe de bact\u00e9ries par diff\u00e9rents m\u00e9canismes d\u2019action<\/strong>.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">De la r\u00e9sistance naturelle \u00e0 la r\u00e9sistance acquise<\/h2>\n\n\n\n<p><strong>Certaines bact\u00e9ries sont naturellement r\u00e9sistantes&nbsp;<\/strong>\u00e0 des antibiotiques, par le biais de diff\u00e9rents m\u00e9canismes&nbsp;:<\/p>\n\n\n\n<ul>\n<li>production d\u2019une enzyme qui modifie ou d\u00e9truit l\u2019antibiotique,<\/li>\n\n\n\n<li>modification de la cible de l\u2019antibiotique,<\/li>\n\n\n\n<li>imperm\u00e9abilit\u00e9 de la membrane de la bact\u00e9rie,<\/li>\n\n\n\n<li>efflux de l\u2019antibiotique hors de la bact\u00e9rie.<\/li>\n<\/ul>\n\n\n\n<p>La plupart du temps, ces m\u00e9canismes de r\u00e9sistances inn\u00e9es sont li\u00e9s \u00e0 la pr\u00e9sence de g\u00e8nes particuliers, localis\u00e9s sur le chromosome de la bact\u00e9rie, et ne concernent qu\u2019un seul antibiotique ou qu\u2019une seule famille d\u2019antibiotiques. Mais une bact\u00e9rie peut acqu\u00e9rir un, plusieurs, voire l\u2019ensemble de tous ces m\u00e9canismes de r\u00e9sistance et devenir ainsi r\u00e9sistante \u00e0 un ou plusieurs antibiotiques auxquels elle \u00e9tait sensible auparavant. Ces r\u00e9sistances peuvent \u00eatre secondaires \u00e0 l\u2019apparition d\u2019une&nbsp;<strong>mutation g\u00e9n\u00e9tique<\/strong>&nbsp;qui affecte le chromosome de la bact\u00e9rie, ou, le plus souvent, \u00e0 l\u2019<strong>acquisition de mat\u00e9riel g\u00e9n\u00e9tique (plasmide, transposon)&nbsp;<\/strong><strong>issu d\u2019une autre bact\u00e9rie, porteur d\u2019un ou plusieurs g\u00e8nes de r\u00e9sistance<\/strong>. Les r\u00e9sistances plasmidiques repr\u00e9sentent 80&nbsp;% des r\u00e9sistances acquises et peuvent concerner plusieurs antibiotiques, voire plusieurs familles d\u2019antibiotiques.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">L\u2019antibior\u00e9sistance\u00a0: point sur la situation en France<\/h2>\n\n\n\n<p>En France, la surveillance continue de l\u2019antibior\u00e9sistance dans les \u00e9tablissements de sant\u00e9 (<a href=\"https:\/\/www.preventioninfection.fr\/spares-surveillance-et-prevention-de-lantibioresistance-en-etablissements-de-sante\/\">mission Spares<\/a>) et en ville (<a href=\"https:\/\/www.preventioninfection.fr\/primo-prevention-des-infections-associees-aux-soins-et-antibioresistance-en-ville-et-medico-social\/\">mission Primo<\/a>) permet d\u2019identifier les menaces \u00e9mergentes ou persistantes, de mettre en place des actions correctrices de ces ph\u00e9nom\u00e8nes et d\u2019en suivre l\u2019efficacit\u00e9. Les derniers chiffres disponibles (2022) montrent que la consommation globale d\u2019antibiotiques est en augmentation, notamment celle de mol\u00e9cules \u00e0 large spectre (qui ciblent plusieurs esp\u00e8ces de bact\u00e9ries) et des antibiotiques r\u00e9cents efficaces contre les bact\u00e9ries multir\u00e9sistantes. La surveillance reste donc de mise afin d\u2019\u00e9valuer les r\u00e9percussions de ces \u00e9volutions.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Un programme prioritaire de recherche pilot\u00e9 par l\u2019Inserm<\/h2>\n\n\n\n<p>Initi\u00e9 en 2020 dans le cadre du programme d\u2019investissement d\u2019avenir de l\u2019\u00c9tat fran\u00e7ais (PIA3) et dot\u00e9 de 40 millions d\u2019euros sur 10 ans, un programme prioritaire de recherche pilot\u00e9 par l\u2019Inserm vise \u00e0 d\u00e9velopper de nouvelles strat\u00e9gies et de nouvelles mesures pour optimiser l\u2019usage des antibiotiques et inverser la courbe de&nbsp;pr\u00e9valence&nbsp;des r\u00e9sistances.<\/p>\n\n\n\n<p>Les projets de recherche financ\u00e9s dans ce programme s\u2019articulent autour de 4 grandes th\u00e9matiques&nbsp;: dynamiques et contr\u00f4le de l\u2019\u00e9mergence, de la transmission et de la diss\u00e9mination des r\u00e9sistances dans toutes les dimensions du&nbsp;<em><bdo dir=\"ltr\">One Health<\/bdo><\/em>, optimisation de l\u2019usage des antibiotiques en m\u00e9decine humaine et v\u00e9t\u00e9rinaire, d\u00e9terminants individuels, ethnologiques et sociologiques, \u00e9conomiques, politiques et culturels de l\u2019antibior\u00e9sistance, et innovation th\u00e9rapeutique. Ils portent sur des th\u00e9matiques aussi diversifi\u00e9es que la dynamique des transmissions bact\u00e9riennes Homme-animal et leur diss\u00e9mination dans les \u00e9cosyst\u00e8mes, les \u00e9tudes de caract\u00e9risation des communaut\u00e9s bact\u00e9riennes (y compris celles du sol) et leur r\u00e9sistance, l\u2019\u00e9tude de nouvelles cibles bact\u00e9riennes, d\u2019antibiotiques et de th\u00e9rapies alternatives aux antibiotiques, ainsi que des \u00e9tudes visant au bon usage d\u2019antibiotiques afin d\u2019en r\u00e9duire leur consommation chez l\u2019humain. S\u2019y ajoutent trois projets \u00ab&nbsp;structurants&nbsp;\u00bb (plateforme&nbsp;<a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/projets-actions-soutenus\/action-2-resultats-des-aap-structurants-du-ppr-antibioresistance-3-projets-retenus\/#abromicspf\">ABRomics<\/a>&nbsp;et r\u00e9seaux&nbsp;<a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/projets-actions-soutenus\/action-2-resultats-des-aap-structurants-du-ppr-antibioresistance-3-projets-retenus\/#promise\">Promise<\/a>&nbsp;et&nbsp;<a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/projets-actions-soutenus\/action-2-resultats-des-aap-structurants-du-ppr-antibioresistance-3-projets-retenus\/#dosa\">Dosa<\/a>), pour la mise en commun des donn\u00e9es, des expertises et des besoins.<\/p>\n\n\n\n<p>Enfin, le programme s\u2019est investi dans l\u2019organisation et la structuration de&nbsp;<a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/projets-actions-soutenus\/action-3-reseau-avec-les-pays-a-ressources-limitees-du-ppr-antibioresistance-developpement-de-2-projets-de-recherche\/\">deux projets de recherche avec des partenaires \u00e0 Madagascar, au Cambodge, en C\u00f4te d\u2019Ivoire et au Burkina Faso<\/a>. Le projet RAMSES a pour ambition d\u2019\u00e9tudier les facteurs socio-\u00e9conomiques et de r\u00e9gulations qui influent l\u2019\u00e9mergence et la diss\u00e9mination des r\u00e9sistances dans les 4 pays. Le projet CircUs vise quant \u00e0 lui \u00e0 analyser la circulation des ent\u00e9robact\u00e9ries multir\u00e9sistances chez les humains, les animaux et l\u2019environnement dans les zones rurales et p\u00e9riurbaines.<\/p>\n\n\n\n<p><a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/\">Pour en savoir plus sur le programme prioritaire de recherche Antibior\u00e9sistance<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Voir l&#8217;article en entier ici : R\u00e9sistance aux antibiotiques \u00b7 Inserm, La science pour la sant\u00e9 Les antibiotiques ont permis de faire consid\u00e9rablement reculer la mortalit\u00e9 associ\u00e9e aux maladies infectieuses au cours du 20e&nbsp;si\u00e8cle. H\u00e9las, leur utilisation massive et r\u00e9p\u00e9t\u00e9e a conduit \u00e0 l\u2019apparition de bact\u00e9ries r\u00e9sistantes \u00e0 ces m\u00e9dicaments. Qui plus est, les animaux [&hellip;]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[6607,6707,6698,6621],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-19T12:23:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-19T12:46:34+00:00\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant\",\"datePublished\":\"2024-08-19T12:23:42+00:00\",\"dateModified\":\"2024-08-19T12:46:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\"},\"wordCount\":905,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"keywords\":[\"Antibior\u00e9sistance\",\"Antibiotiques\",\"Antimicrobial Resistance\",\"OneHealth\"],\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\",\"name\":\"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"datePublished\":\"2024-08-19T12:23:42+00:00\",\"dateModified\":\"2024-08-19T12:46:34+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/","og_locale":"en_GB","og_type":"article","og_title":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2024-08-19T12:23:42+00:00","article_modified_time":"2024-08-19T12:46:34+00:00","author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kevin Gr\u00e9goire","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant","datePublished":"2024-08-19T12:23:42+00:00","dateModified":"2024-08-19T12:46:34+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/"},"wordCount":905,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"keywords":["Antibior\u00e9sistance","Antibiotiques","Antimicrobial Resistance","OneHealth"],"articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/","name":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"datePublished":"2024-08-19T12:23:42+00:00","dateModified":"2024-08-19T12:46:34+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/resistance-aux-antibiotiques-un-phenomene-massif-et-preoccupant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"R\u00e9sistance aux antibiotiques, un ph\u00e9nom\u00e8ne massif et pr\u00e9occupant"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-14 20:27:55","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29729"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=29729"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29729\/revisions"}],"predecessor-version":[{"id":29734,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/29729\/revisions\/29734"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=29729"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=29729"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=29729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}